desk
Share
News Topical, Digital Desk : Q2 Results: Shares of biotech company Advanced Enzyme Technologies Ltd. jumped 9% on Wednesday, November 12. This surge came after the company reported strong September quarter (Q2) results.
The company released its results during market hours. Net profit increased 32% year-on-year (YoY) to ₹43.3 crore, compared to ₹33 crore in the same quarter last year. Revenue also saw strong growth, rising 26.4% to ₹184.5 crore, compared to ₹146 crore in the same quarter last year. The company's EBITDA (earnings before interest, tax, depreciation, and amortization) increased 42% to ₹60 crore, compared to ₹42.3 crore in the same quarter last year. EBITDA margin also
expanded 350 basis points from 29% to 32.5%. The company did not declare any dividend. In 2017, Advanced Enzymes split its equity share of ₹10 into five shares of ₹2 each.
Shares surged 8% after the results announcement, with Advanced Enzyme shares trading at ₹329.75 on Wednesday. While the stock is down 6% so far in 2025, it has recovered by a similar amount over the past month. Trading volumes on Wednesday were unusually high, with over 9.5 lakh shares of the company trading, compared to the average of just 53,000 shares over the past 20 days. Overall, strong operating performance and rising profits have given Advanced Enzyme investors renewed hope.
Read More: Rupee hits historic low against dollar; what is the reason?
--Advertisement--
